home / stock / bmy / bmy articles


BMY Articles, Bristol-Myers Squibb Company - From 03/15/24

Stock Information

Company Name: Bristol-Myers Squibb Company
Stock Symbol: BMY
Market: NYSE
Website: bms.com

Menu

BMY BMY Quote BMY Short BMY News BMY Articles BMY Message Board
Get BMY Alerts

News, Short Squeeze, Breakout and More Instantly...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY | Benzinga

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bristol-Myers Squibb Company ("Bris...

What's Going On With Cancer Focused-Geron Stock On Friday? | Benzinga

Friday, Geron Corporation’s (NASDAQ:GERN) shares are trading lower with a high session volume of 5.82 million compared to the avera...

FDA To Review Two Cell Therapies For Multiple Myeloma This Week - Johnson & Johnson And Bristol-Myers | Benzinga

On Friday, 15 March, the FDA’s Oncologic Drugs Advisory Committee will meet to discuss Johnson & Johnson (NYSE:JNJ) / ...

Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley | Benzinga

Morgan Stanley initiates Arcellx Inc (NASDAQ:ACLX), noting a differentiated CAR-T platform for blood cancer backed by an established...

Medicare's Ambitious Drug Price Negotiation Plan: President Joe Biden Calls To Expand Targeted Medicines To 50 Annually by 2029 | Benzinga

In a move outlined in his upcoming State of the Union address, President Joe Biden is pushing for an increase in the number of prescripti...

Biden's State Of The Union: Grading His Results On Abortion Access, Drug Prices And Opium Epidemic | Benzinga

As President Joe Biden prepares for his State of the Union address on Thursday, he's expected to touch on several key issues including Bidenom...

Large US Drug Makers Highlight Indian Market For Their Blockbuster Drugs Including For Weight Loss | Benzinga

Eli Lilly And Co’s (NYSE:LLY) CEO, David Ricks, shared the pharmaceutical giant’s plans to introduce its obesity drug, tirzepatide...

Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial | Benzinga

Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combinat...

Top Cannabis Appointments You Should Know About: Aurora's New CFO And Other Changes | Benzinga

New Cannabis CEOs, CFOs And Other Appointments Canadian medical cannabis giant Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) announced on Tuesday tha...

Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields | Benzinga

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have hig...

Previous 10 Next 10